Publicaciones en las que colabora con M. Dolores García Vázquez (10)

2020

  1. Serum markers improve current prediction of metastasis development in early-stage melanoma patients: a machine learning-based study

    Molecular Oncology, Vol. 14, Núm. 8, pp. 1705-1718

2016

  1. Vitronectin and dermcidin serum levels predict the metastatic progression of AJCC I–II early-stage melanoma

    International Journal of Cancer, Vol. 139, Núm. 7, pp. 1598-1607

2003

  1. Implicación del sistema de la interleucina-2 y su receptor en la evolución del melanoma humano. Valor pronóstico

    Implicación del sistema de la interleucina-2 y su receptor en la evolución del melanoma humano. Valor pronóstico

2001

  1. Effect of IL-2 and IL-6 on parameters related to metastatic activity in a murine melanoma

    Pathobiology, Vol. 69, Núm. 4, pp. 230-236

2000

  1. Interleukin-2 enhances the growth of human melanoma cells derived from primary but not from metastatic tumours

    European Cytokine Network, Vol. 11, Núm. 4, pp. 654-661

  2. Soluble interleukin-2 receptor, intercellular adhesion molecule-1 and interleukin-10 serum levels in patients with melanoma

    British Journal of Cancer, Vol. 83, Núm. 7, pp. 847-852

1998

  1. Cyclosporin A upmodulates the α-subunit of the interleukin-2 receptor and the metastatic ability of murine B16F10 melanoma cells

    Invasion and Metastasis, Vol. 18, Núm. 3, pp. 122-133

1997

  1. Serum-soluble IL-2 Receptor and IL-6 levels in patients with melanoma

    Oncology (Switzerland), Vol. 54, Núm. 5, pp. 400-406

1996

  1. Expression of IL-2 receptor beta-chain in B16 melanoma cells.

    The International journal of developmental biology, Vol. Suppl 1

  2. Serum interleukin-6 levels in patients with melanoma.

    The International journal of developmental biology, Vol. Suppl 1